Susan L. Mooberry

The University of Texas Health Science Center at San Antonio — United States

Medicine · Health Sciences

48h-index7.7kcitations246works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microbial Natural Products and Biosynthesis(50), Microtubule and mitosis dynamics(49), Cancer Treatment and Pharmacology(48), Synthesis and biological activity(40), Marine Sponges and Natural Products(30)

Publications246 total

Latrunculin U: a potent actin-disrupter from the Red Sea marine sponge <i>Negombata magnifica</i>
Natural Product Research·2025· 1 citedOpen Access
Synthesis and structure-activity relationship of boronic acid bioisosteres of combretastatin A-4 as anticancer agents
Bioorganic & Medicinal Chemistry·2024· 3 citedOpen Access
Synthesis and Structure-Activity Relationship of Boronic Acid Bioisosteres of Combretastatin A-4 as Anticancer Agents
SSRN Electronic Journal·2024Open Access
Abstract 6397: Eribulin acts as an immune adjuvant to enhance the antitumor efficacy of STING agonists in triple-negative breast cancer models
Cancer Research·2023
429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
Journal of Clinical and Translational Science·2023Open Access
Supplementary Figure 2 from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Supplementary Figure 3 from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Supplementary Figure 1 from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Supplementary Legends from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Supplementary Figure 3 from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Data from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Data from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Supplementary Legends from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Supplementary Figure 2 from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Supplementary Figure 1 from The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
2023Open Access
Abstract P4-07-19: Eribulin enhances STING-dependent induction of type I interferons in immune and triple-negative breast cancer cells
Cancer Research·2023
Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine site
Bioorganic & Medicinal Chemistry·2023· 7 citedOpen Access
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
Cancers·2022· 30 citedOpen Access
Eribulin Enhances Interferon Production by STING Agonists in Models of Triple‐Negative Breast Cancer
The FASEB Journal·2022
Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents
Molecules·2022· 9 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

April L. Risinger(8), Richard E. Moore(7), William H. Gerwick(7), Wesley Y. Yoshida(7), Rachel M. Leal(6), Hendrik Luesch(5), Valerie J. Paul(5), Thomas H. Corbett(5), Douglas E. Goeger(5), Frederick A. Valeriote(5), Evelyn M. Jackson(4), Patrice Hills(4), Kerry L. McPhail(4), Harald Gross(4), Ernest Hamel(4), Robert H. Cichewicz(4), Phillip Crews(4), Tina L. Tinley(3), Deborah A. Randall‐Hlubek(3), Thomas Hemscheidt(3)